J. M. Gregory

Genetics of Amyotrophic Lateral Sclerosis

H. Phatnani, D. Fagegaltier, M. Harms, 2020, Current Genetic Medicine Reports.

40 Years of CSF Toxicity Studies in ALS: What Have We Learnt About ALS Pathophysiology?

S. Chandran, G. Hardingham, S. Pal, 2021, Frontiers in Molecular Neuroscience.

An epidemiological profile of dysarthria incidence and assistive technology use in the living population of people with MND in Scotland

S. Chandran, S. Colville, S. Pal, 2019, Amyotrophic lateral sclerosis & frontotemporal degeneration.

Therapeutic Targeting of Proteostasis in Amyotrophic Lateral Sclerosis—a Systematic Review and Meta-Analysis of Preclinical Research

S. Chandran, G. Hardingham, Fergal M. Waldron, 2020, Frontiers in Neuroscience.

Executive, language and fluency dysfunction are markers of localised TDP-43 cerebral pathology in non-demented ALS

Colin Smith, S. Chandran, T. Bak, 2019, Journal of Neurology, Neurosurgery, and Psychiatry.